Morning Briefing #114 — July 29, 2026

Morning Briefing #114 — July 29, 2026Your daily briefing connecting world events, technology, and education.No political slant. Just facts.━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━📋 IN TODAY'S EPISODE━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━🌍 WHAT'S HAPPENING IN THE WORLD────────────────────────────────Trump and Netanyahu Meet at the White House as the Iran War Enters a New Diplomatic PhasePresident Trump and Israeli Prime Minister Benjamin Netanyahu held a 90-minute Oval Office meeting Tuesday focused on the ongoing war with Iran, nearly five months after the two jointly launched a regime-change effort there. A White House official said the talks covered strikes, military strategy, and a path toward de-escalation, alongside discussion of expanding the Abraham Accords. Both sides characterized the meeting as "productive," though reporting has noted a widening gap between Washington and Jerusalem over how the conflict should end. Netanyahu said afterward the two have "a mutual understanding that the goal is to prevent Iran from getting a nuclear weapon."Wildfires Force Mass Evacuations Across France and Spain as a Fourth Heat Wave BuildsFirefighters in southern France and central Spain are racing to contain ferocious wildfires before a fresh heat wave arrives this week, with temperatures forecast to top 104°F in parts of Spain. Roughly 220,000 people have been evacuated from France's Gironde region, while Spain has evacuated about 79,000 more and declared a national wildfire emergency for the first time. French President Emmanuel Macron called it the toughest crisis of its kind "since the Second World War," and roughly 800 square kilometers have already burned in Spain alone.Oxford Scientist Behind Landmark Malaria Vaccine Wins Top European Inventor PrizeSir Adrian Hill, who led development of the R21/Matrix-M malaria vaccine at Oxford, has won the European Patent Office's European Inventor Award 2026 in the research category. The vaccine achieved roughly 80% protection in clinical trials — beating WHO targets — costs less than €3 a dose, and stays stable for up to two years under normal refrigeration. It has now rolled out across some 20 countries, built with partners including the Serum Institute of India, Novavax, and research centers in Burkina Faso, Kenya, Mali, and Tanzania, and is credited with helping prevent tens of thousands of malaria deaths, most of them children.---💻 THE TECH CONNECTION────────────────────────────────FCC Bars Imports of New Chinese Humanoid and Quadruped RobotsThe FCC issued rules Tuesday barring US imports of new Chinese-made humanoid and quadruped robots, plus connected power inverters, expanding the Trump administration's campaign against Chinese tech. The Covered List designation blocks new models from getting the equipment authorization required to be imported, marketed, or sold in the US — though it doesn't recall robots already in use or stop sales of previously authorized models. Officials framed the move as protecting the US AI supply chain from data theft and cyberattack risk; China currently holds roughly 85% of the global humanoid robot market.AI Security Startups Raise a Record $855 Million as Funding SurgesAI-security startups have raised $855 million across more than 150 seed-stage rounds so far in 2026, on pace for a record year according to Crunchbase data. Standout rounds include identity-intelligence firm Oak ($60 million), AI-native security platform Cylake ($45 million, founded by Palo Alto Networks founder Nir Zuk), and AI governance startup JetStream Security ($34 million). The surge reflects growing investor appetite for tools that secure AI systems themselves, not just the infrastructure around them.---🏫 WHAT THIS MEANS FOR EDUCATION────────────────────────────────(continued in YouTube show notes)